Inhibition of the α-Subunit of Phosphoinositide 3-Kinase in Heart Increases Late Sodium Current and Is Arrhythmogenic

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2018-03-21

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/jpet.117.246157PMID 29563327PMCID PMC5931436
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phosphatidylinositol 3-Kinase α-Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study.

  2018cited by this paper
• Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review

  2018cited by this paper
• Insulin-like growth factor-1 activates different catalytic subunits p110 of PI3K in a cell-type-dependent manner to induce lipogenesis-dependent epithelial–mesenchymal transition through the regulation of ADAM10 and ADAM17

  2018cited by this paper
• Targeting the PI 3 K / AKT / mTOR pathway in triple ‐ negative breast cancer : a review

  2018cited by this paper
• Necessity to evaluate PI3K/Akt signalling pathway in proarrhythmia

  2017cited by this paper
• Phase I Dose-Escalation Study of Taselisib, an Oral PI3K Inhibitor, in Patients with Advanced Solid Tumors.

  2017cited by this paper
• The role of PI3Kα isoform in cardioprotection

  2017cited by this paper
• Role of PI3K p110β in the differentiation of human embryonic stem cells into islet-like cells.

  2017cited by this paper
• Mechanistic Model‐Informed Proarrhythmic Risk Assessment of Drugs: Review of the “CiPA” Initiative and Design of a Prospective Clinical Validation Study

  2017cited by this paper
• Novel pan PI3K inhibitor-induced apoptosis in APL cells correlates with suppression of telomerase: An emerging mechanism of action of BKM120.

  2017cited by this paper
• Evolving regulatory paradigm for proarrhythmic risk assessment for new drugs.

  2016cited by this paper
• Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors.

  2016cited by this paper
• ETP-46321, a dual p110α/δ class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritis.

  2016cited by this paper
• PI3K inhibitors as new cancer therapeutics: implications for clinical trial design

  2016cited by this paper
• Increased Late Sodium Current Contributes to the Electrophysiological Effects of Chronic, but Not Acute, Dofetilide Administration

  2016cited by this paper
• Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate.

  2016cited by this paper
• Cardiac late Na⁺ current: proarrhythmic effects, roles in long QT syndromes, and pathological relationship to CaMKII and oxidative stress.

  2015cited by this paper
• Control of Cardiac Repolarization by Phosphoinositide 3-Kinase Signaling to Ion Channels

  2015cited by this paper
• Population pharmacokinetic modeling of idelalisib, a novel PI3Kδ inhibitor, in healthy subjects and patients with hematologic malignancies

  2015cited by this paper
• Measurement of PIP3 levels reveals an unexpected role for p110β in early adaptive responses to p110α-specific inhibitors in luminal breast cancer.

  2015cited by this paper
• Safety of Oral Dofetilide for Rhythm Control of Atrial Fibrillation and Atrial Flutter

  2015cited by this paper
• Drugging PI3K in cancer: refining targets and therapeutic strategies

  2015cited by this paper
• Screening for Acute IKr Block Is Insufficient to Detect Torsades de Pointes Liability: Role of Late Sodium Current

  2014influential reference
• Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K-Akt signaling.

  2014cited by this paper
• The role of late I Na in development of cardiac arrhythmias.

  2014cited by this paper
• AS252424, a PI3Kγ Inhibitor, Downregulates Inflammatory Responsiveness in Mouse Bone Marrow-Derived Mast Cells

  2014cited by this paper
• Is there a need to add another dimension (time) to the evaluation of the arrhythmogenic potential of new drug candidates in vitro?

  2014cited by this paper
• PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma.

  2014cited by this paper
• Increased Persistent Sodium Current Due to Decreased PI3K Signaling Contributes to QT Prolongation in the Diabetic Heart

  2013cited by this paper
• Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility

  2013cited by this paper
• Overview of Safety Pharmacology

  2013cited by this paper
• PI3K: A potential therapeutic target for cancer

  2012cited by this paper
• Blocking Scn10a Channels in Heart Reduces Late Sodium Current and Is Antiarrhythmic

  2012cited by this paper
• Increased late sodium current contributes to long QT-related arrhythmia susceptibility in female mice.

  2012cited by this paper
• Suppression of Phosphoinositide 3-Kinase Signaling and Alteration of Multiple Ion Currents in Drug-Induced Long QT Syndrome

  2012cited by this paper
• Late Sodium Current Contributes to the Reverse Rate-Dependent Effect of IKr Inhibition on Ventricular Repolarization

  2011cited by this paper
• PI3K pathway-directed therapeutic strategies in cancer.

  2010cited by this paper
• PI3K kinase and scaffold functions in heart

  2010cited by this paper
• The PI3K pathway as drug target in human cancer.

  2010cited by this paper
• Arrhythmogenic liability screening in cardiovascular safety pharmacology: commonality between non-clinical safety pharmacology and clinical thorough QT (TQT) studies.

  2010cited by this paper
• Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillation.

  2009cited by this paper
• Phosphoinositide 3-kinase Akt signaling pathway interacts with protein kinase Cbeta2 in the regulation of physiologic developmental hypertrophy and heart function.

  2009cited by this paper
• PI3K regulatory subunits lose control in cancer.

  2009cited by this paper
• Clinical practice. Long-QT syndrome.

  2008influential reference
• Protein kinase cascades in the regulation of cardiac hypertrophy.

  2005cited by this paper
• High Frequency of Mutations of the PIK3CA Gene in Human Cancers

  2004cited by this paper
• Akt and PI 3-Kinase Signaling in Cardiomyocyte Hypertrophy and Survival

  2003cited by this paper
• The conserved phosphoinositide 3‐kinase pathway determines heart size in mice

  2000cited by this paper
• Inactivation-resistant channels underlying the persistent sodium current in rat ventricular myocytes

  1994cited by this paper
• A persistent sodium current in rat ventricular myocytes.

  1992cited by this paper

• The impact of the PI3K/AKT pathway on arrhythmia: mechanisms of action and therapeutic potential

  2026influential citation
• Cardiovascular toxicity of cyclin-dependent kinase 4 and 6 inhibitors

  2025cites this paper
• A PI3K Inhibitor with Low Cardiotoxicity and Its Synergistic Inhibitory Effect with Gilteritinib in Acute Myelogenous Leukemia (AML) Cells

  2025cites this paper
• Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology

  2025cites this paper
• A real-world pharmacovigilance study of QT interval prolongation and Torsades de Pointes associated with CDK4/6 inhibitors in breast cancer patients: findings from the FDA adverse event reporting system

  2024cites this paper
• The potential anti-arrhythmic effect of SGLT2 inhibitors

  2024cites this paper
• Contractility measurements for cardiotoxicity screening with ventricular myocardial slices of pigs

  2023cites this paper
• Cardiotoxicities of Non-Chemotherapeutic Metastatic Breast Cancer Treatments

  2023cites this paper
• Inhibition of late sodium current via PI3K/Akt signaling prevents cellular remodeling in tachypacing-induced HL-1 atrial myocytes

  2022cites this paper
• Transcriptional Dysregulation Underlies Both Monogenic Arrhythmia Syndrome and Common Modifiers of Cardiac Repolarization

  2022cites this paper
• Pharmacogenomics for Prediction of Cardiovascular Toxicity: Landscape of Emerging Data in Breast Cancer Therapies

  2022cites this paper
• Pumping actions of the heart

  2021cites this paper
• Sexual Dimorphisms, Anti-Hormonal Therapy and Cardiac Arrhythmias

  2021cites this paper
• Submission for Special Issue: The Role of Platelet Activation in the Pathophysiology of HIV, Tuberculosis, and Pneumococcal Disease. Bedaquiline Suppresses ADP-Mediated Activation of Human Platelets In Vitro via Interference With Phosphatidylinositol 3-Kinase

  2021cites this paper
• The Molecular Mechanisms of Cardiotoxicity Induced by HER2, VEGF, and Tyrosine Kinase Inhibitors: an Updated Review

  2021cites this paper
• Cardiovascular toxicity of breast cancer treatment: an update

  2021cites this paper
• Isoform-Selective PI3K Inhibitors for Various Diseases.

  2020cites this paper
• Cardiovascular toxicity of PI3Kα inhibitors.

  2020cites this paper
• Cardioprotective properties of the platelet P2Y12 receptor inhibitor prasugrel on cardiac ischemia/reperfusion injury

  2020cites this paper
• Alpelisib in the treatment of metastatic HR+ breast cancer with PIK3CA mutations.

  2020cites this paper
• The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia

  2020cites this paper
• Genetic susceptibility in pharmacodynamic and pharmacokinetic pathways underlying drug-induced arrhythmia and sudden unexplained deaths.

  2019cites this paper
• Inhibition of PI3Kinase-α is pro-arrhythmic and associated with enhanced late Na+ current, contractility, and Ca2+ release in murine hearts.

  2019cites this paper
• Cardiac arrhythmia considerations of hormone cancer therapies

  2019cites this paper
• A current understanding of drug-induced QT prolongation and its implications for anticancer therapy.

  2019cites this paper
• Multiple mechanisms underlie increased cardiac late sodium current.

  2019cites this paper
• Safety and Tolerability of Phosphatidylinositol-3-Kinase (PI3K) Inhibitors in Oncology

  2019cites this paper
• PI3Kα in cardioprotection: Cytoskeleton, late Na+ current, and mechanism of arrhythmias

  2019cites this paper
• Androgenic Effects on Ventricular Repolarization: A Translational Study From the International Pharmacovigilance Database to iPSC-Cardiomyocytes.

  2019cites this paper
• PI3Kinases in Diabetes Mellitus and Its Related Complications

  2018cites this paper
• Phosphorylation of cardiac voltage‐gated sodium channel: Potential players with multiple dimensions

  2018cites this paper